Hisamitsu Pharmaceutical Co., Inc.

TSE:4530 Voorraadrapport

Marktkapitalisatie: JP¥328.6b

Hisamitsu Pharmaceutical Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Hisamitsu Pharmaceutical has a total shareholder equity of ¥275.9B and total debt of ¥1.1B, which brings its debt-to-equity ratio to 0.4%. Its total assets and total liabilities are ¥350.5B and ¥74.6B respectively. Hisamitsu Pharmaceutical's EBIT is ¥13.8B making its interest coverage ratio -3.4. It has cash and short-term investments of ¥122.7B.

Belangrijke informatie

0.4%

Verhouding schuld/eigen vermogen

JP¥1.12b

Schuld

Rente dekkingsratio-3.4x
ContantJP¥122.74b
AandelenJP¥275.93b
Totaal verplichtingenJP¥74.55b
Totaal activaJP¥350.48b

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Hisamitsu Pharmaceutical's (TSE:4530) Solid Earnings May Rest On Weak Foundations

Oct 17
Hisamitsu Pharmaceutical's (TSE:4530) Solid Earnings May Rest On Weak Foundations

Hisamitsu Pharmaceutical Co., Inc. (TSE:4530) Not Lagging Market On Growth Or Pricing

Sep 16
Hisamitsu Pharmaceutical Co., Inc. (TSE:4530) Not Lagging Market On Growth Or Pricing

Hisamitsu Pharmaceutical's (TSE:4530) Shareholders Will Receive A Bigger Dividend Than Last Year

Aug 20
Hisamitsu Pharmaceutical's (TSE:4530) Shareholders Will Receive A Bigger Dividend Than Last Year

Hisamitsu Pharmaceutical (TSE:4530) Has Announced That It Will Be Increasing Its Dividend To ¥45.00

Jul 26
Hisamitsu Pharmaceutical (TSE:4530) Has Announced That It Will Be Increasing Its Dividend To ¥45.00

Hisamitsu Pharmaceutical (TSE:4530) Is Paying Out A Larger Dividend Than Last Year

Jul 11
Hisamitsu Pharmaceutical (TSE:4530) Is Paying Out A Larger Dividend Than Last Year

Hisamitsu Pharmaceutical's (TSE:4530) Dividend Will Be Increased To ¥45.00

Jun 27
Hisamitsu Pharmaceutical's (TSE:4530) Dividend Will Be Increased To ¥45.00

Hisamitsu Pharmaceutical (TSE:4530) Is Increasing Its Dividend To ¥45.00

Jun 13
Hisamitsu Pharmaceutical (TSE:4530) Is Increasing Its Dividend To ¥45.00

Why We're Not Concerned About Hisamitsu Pharmaceutical Co., Inc.'s (TSE:4530) Share Price

Apr 09
Why We're Not Concerned About Hisamitsu Pharmaceutical Co., Inc.'s (TSE:4530) Share Price

Here's Why We Think Hisamitsu Pharmaceutical (TSE:4530) Is Well Worth Watching

Mar 18
Here's Why We Think Hisamitsu Pharmaceutical (TSE:4530) Is Well Worth Watching

Analyse van de financiële positie

Kortlopende schulden: 4530's short term assets (¥207.0B) exceed its short term liabilities (¥58.6B).

Langlopende schulden: 4530's short term assets (¥207.0B) exceed its long term liabilities (¥15.9B).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: 4530 has more cash than its total debt.

Schuld verminderen: 4530's debt to equity ratio has reduced from 0.7% to 0.4% over the past 5 years.

Schuldendekking: 4530's debt is well covered by operating cash flow (1664.5%).

Rentedekking: 4530 earns more interest than it pays, so coverage of interest payments is not a concern.

Balans

Ontdek gezonde bedrijven

7D

1Y

7D

1Y

7D

1Y